An innovative and reliable approach using monocyte-derived hepatocyte-like (MH) cells has demonstrated high sensitivity and specificity in the diagnosis of idiosyncratic drug-induced liver injury (iDILI), according to data presented at the International Digestive Disease Forum (IDDF) organized by the Chinese University of Hong Kong (CUHK).
Vonoprazan, a novel potassium-competitive acid blocker (P-CAB), is at least as effective as proton-pump inhibitors (PPIs) in the treatment of acid-related disorders, according to results of Japanese studies reported at the International Digestive Disease Forum (IDDF) 2019.
Asia's trusted medical magazine for healthcare professionals.
Get your MIMS Hepatology - Malaysia digital copy today!
Treatment with nidufexor led to significantly reduced serum alanine aminotransferase (ALT) levels and hepatic fat fraction in patients with nonalcoholic steatohepatitis (NASH), according to a phase II study presented at ILC 2020.
A trivalent vaccine against hepatitis (hep B) is safe and effectively elicits robust immune response compared with a monovalent Hep B vaccine, according to the PROTECT and CONSTANT studies presented during the 2020 digital ILC.